Product NDC: | 50419-344 |
Proprietary Name: | Ultravist |
Non Proprietary Name: | iopromide |
Active Ingredient(s): | 623.4 mg/mL & nbsp; iopromide |
Administration Route(s): | INTRA-ARTERIAL |
Dosage Form(s): | INJECTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 50419-344 |
Labeler Name: | Bayer HealthCare Pharmaceuticals Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA021425 |
Marketing Category: | NDA |
Start Marketing Date: | 20091230 |
Package NDC: | 50419-344-07 |
Package Description: | 10 VIAL, GLASS in 1 CARTON (50419-344-07) > 75 mL in 1 VIAL, GLASS |
NDC Code | 50419-344-07 |
Proprietary Name | Ultravist |
Package Description | 10 VIAL, GLASS in 1 CARTON (50419-344-07) > 75 mL in 1 VIAL, GLASS |
Product NDC | 50419-344 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | iopromide |
Dosage Form Name | INJECTION |
Route Name | INTRA-ARTERIAL |
Start Marketing Date | 20091230 |
Marketing Category Name | NDA |
Labeler Name | Bayer HealthCare Pharmaceuticals Inc. |
Substance Name | IOPROMIDE |
Strength Number | 623.4 |
Strength Unit | mg/mL |
Pharmaceutical Classes | Radiographic Contrast Agent [EPC],X-Ray Contrast Activity [MoA] |